MRNA Retained Earnings History: $7.22B (FY2025)

Fiscal year	Q1	Q2	Q3	Q4
FY26	$5.9B−35.2%	Not reported	Not reported	Not reported
FY25	$9.1B−27.0%	$8.2B−26.0%	$8.0B−27.9%	$7.2B−28.1%
FY24	$12.4B−32.4%	$11.2B−34.5%	$11.2B−16.6%	$10.0B−26.2%
FY23	$18.4B+35.1%	$17.0B+7.6%	$13.4B−20.6%	$13.6B−25.7%
FY22	$13.6B+1430.9%	$15.8B+799.9%	$16.9B+231.1%	$18.3B+84.0%

01—History

Retained Earnings History

Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.

$7.22B

YoY changeLargest recent move+84.0%in FY22Latest −28.1%

1 older move runs past ±150% (largest +543.8%); point at, tap or drag across the bars to read one.

02—Ledger

Retained Earnings, period by period

Period	Value	Change	Source
FY2025	$7.22B	−28.1%	10-K
FY2024	$10.04B	−26.2%	10-K
FY2023	$13.61B	−25.7%	10-K
FY2022	$18.32B	+84.0%	10-K
FY2021	$9.96B	+543.8%	10-K
FY2020	−$2.24B	−50.0%	10-K
FY2019	−$1.50B	−48.7%	10-K
FY2018	−$1.01B	−61.9%	10-K
FY2017	−$621.9M	—	10-K

03—Questions

What is retained earnings?

Retained earnings represent the cumulative net income that has been reinvested in the business rather than distributed as dividends to shareholders.

What is Moderna, Inc.'s current retained earnings?

Moderna, Inc. (MRNA) annual retained earnings for 2025 was $7.22B, a 28.09% decline from 2024. Moderna, Inc. retained earnings for the quarter ending March 31, 2026 was $5.88B.

What was Moderna, Inc.'s retained earnings in 2024?

Moderna, Inc. annual retained earnings for 2024 was $10.04B, a 26.17% decline from 2023.

What was Moderna, Inc.'s retained earnings in 2023?

Moderna, Inc. annual retained earnings for 2023 was $13.61B, a 25.73% decline from 2022.

Company: Moderna, Inc.
Ticker: MRNA
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Moderna, Inc. Retained Earnings 2017-2026 | MRNA

Key Statistics